Nexeon MedSystems

Nexeon MedSystems Inc
Industry Bioelectronics
Founded 2005
Founder Mark C. Bates
Headquarters Dallas, TX, United States
Key people
 William Rosellini, Chairman, Co-Founder, and Chief Executive Officer.,[1] Brian Blischak, Chief Commercial Officer[2]
Products Implantable medical devices
Website www.nexeonmed.com

Nexeon MedSystems,OTC:QB NXNN Inc. is an bioelectronics company focused on providing innovative neurostimulation products that improve the quality of life of patients suffering from debilitating neurological disease. Nexeon has developed and commercialized the Synapse™ neurostimulation system, an adaptive, closed-loop platform that can be utilized to treat a variety of neurological diseases.[3][4]

History

Nexeon MedSystems Inc was originally founded in 2005 by Dr. Mark C. Bates under the name Paragon Intellectual Properties.[5] In 2008, the company restructured and become Nexeon.[6][7]

In 2015, Nexeon underwent a change of control and was incorporated in the state of Nevada and has headquarters in Dallas, TX, with subsidiaries in San Juan, Puerto Rico, and Liege, Belgium.[5] In December 2015, a transaction was agreed upon that led to the creation of a new Nexeon MedSystems Inc. (a Nevada based c-corp) to house the assets associated with this entity.[8]

Products and services

Nexeon MedSystems develops and manufactures external and implantable med-tech products and the corresponding remote monitoring and data acquisition IT systems for the relief of chronic diseases and disorders.[9][10][11]

See also

References

  1. ↑ Dean, Takahashi (28 October 2016). "Scientist breaks down Deus Ex: Mankind Divided's human augmentation tech". venturebeat.com. Retrieved 8 December 2016.
  2. ↑ Tabitha, Berg (17 October 2016). "Neurotech Leaders Forum 2016 in San Francisco Welcomes Key Startups and Industry Figures". enewschannels.com. Retrieved 8 December 2016.
  3. ↑ Josh, Baxt (12 September 2016). "Nexeon MedSystems to take on the likes of Medtronic as it readies to go public". medcitynews.com. Retrieved 8 December 2016.
  4. ↑ "Bioelectronics: moves humans to robotic". computescotland.com. 17 November 2016. Retrieved 8 December 2016.
  5. 1 2 "Company Overview of Nexeon MedSystems, Inc". bloomberg.com. Retrieved 8 December 2016.
  6. ↑ "Paragon Intellectual Properties Restructures Company to Form Nexeon MedSystems". nanowerk.com. 7 October 2008. Retrieved 8 December 2016.
  7. ↑ "Nexeon Medsystems adquirirá Rosellini Scientific Benelux". phmk.es. 26 October 2016. Retrieved 8 December 2016.
  8. ↑ "Investigan nuevos procedimientos para extender el sistema nervioso". elmundofinanciero.com. Retrieved 8 December 2016.
  9. ↑ "Nexeon Medsystems verwerft controle over Rosellini Scientific Benelux". dvo.be. 13 November 2016. Retrieved 8 December 2016.
  10. ↑ Marguerite, Chambers (5 December 2016). "Form D: Nexeon Medsystems $5.50 million Fundraising. RON CONQUEST Submitted Dec 5 D form". friscofastball.com. Retrieved 8 December 2016.
  11. ↑ "Le Gouvernement fait progresser la bioélectronique en circuit fermé". informaticien.be. 17 November 2016. Retrieved 8 December 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.